Pharmaceuticals: working towards
excellent healthcare for all
The pharmaceutical industry is currently facing major challenges, linked to the strong rise in temperature-sensitive biotechnology products and tightening regulations.
In just a few short years, cold-chain logistics has become a key issue for the pharmaceutical industry.
The global market for temperature-controlled logistics for healthcare products was worth $78.5 billion in 2021 and is expected to grow at an impressive annual rate of 8.6% between 2022 and 2030 (IATA).
High standards for ultra-sensitive products
We will never break the cold chain for highly sensitive medicines and have made this promise a top priority in our airports.
At the heart of a major pharmaceutical hub, Groupe ADP guarantees compliance with the highest transport and storage standards to preserve the integrity of your pharmaceutical products and ensure they reach their destination in the shortest possible time, on every continent.
Our assets:
• 18,000 sq.m of temperature-controlled surface area
• a "CEIV Pharma” community certification process with International Air Transport Association (IATA)
• 8 major air freight operators are CEIV Pharma certified
• 5 operators are IATA Pharma approved